FDA Panel To Consider Antimicrobial Effectiveness, Classifications Of Wound Dressings
Executive Summary
In light of recent advances in wound-care technology, US FDA is asking its General and Plastic Surgery Devices advisory panel to discuss indications for use, and safety and effectiveness of the latest drug-containing wound dressings, as well as antimicrobial effectiveness of dressings, at a Sept. 20-21 meeting.
You may also be interested in...
FDA Panel Supports Class II For Wound Dressings, But More Controls When Antibiotics Are Added
Most experts on US FDA’s General & Plastic Surgery Devices Advisory Committee recommended Sept. 21 that drug-containing wound dressings should be placed in the class II risk category, but some pushed for more oversight of products containing antibiotics, with some panelists recommending class III placement in those instances.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.
HHS Secretary Nominee Becerra Commits To Telehealth Expansion, Procedure Price Transparency
At two recent confirmation hearings, HHS secretary nominee Xavier Becerra promised Senators he would help expand telehealth and procedure price transparency.